Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Breast Cancer”

558 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 558 results

Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Testing effectiveness (Phase 2)Study completedNCT02834403
What this trial is testing

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute 37
Early research (Phase 1)Study completedNCT00426556
What this trial is testing

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 88
Not applicableStudy completedNCT00115505
What this trial is testing

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Alliance for Clinical Trials in Oncology 307
Early research (Phase 1)Not Yet RecruitingNCT07408856
What this trial is testing

CAN1012 in Pre-Malignant DCIS and LCIS

Who this might be right for
Ductal Carcinoma in SituLobular Carcinoma in Situ
Providence Health & Services 24
Testing effectiveness (Phase 2)Study completedNCT02654119
What this trial is testing

Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

Who this might be right for
HER2 Positive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
University of Nebraska 20
Early research (Phase 1)WithdrawnNCT00635245
What this trial is testing

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Pfizer
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Early research (Phase 1)Study completedNCT03246009
What this trial is testing

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Who this might be right for
Chemotherapy-induced NeutropeniaCancer, Breast
Tianjin SinoBiotech Ltd. 24
Early research (Phase 1)Study completedNCT03807765
What this trial is testing

Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

Who this might be right for
Metastatic Breast CancerBrain Metastases
H. Lee Moffitt Cancer Center and Research Institute 14
Early research (Phase 1)Active Not RecruitingNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT02129556
What this trial is testing

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 58
Large-scale testing (Phase 3)Active Not RecruitingNCT00310180
What this trial is testing

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Who this might be right for
Breast AdenocarcinomaHormone Receptor PositiveStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 10,273
Early research (Phase 1)Study completedNCT02088684
What this trial is testing

Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 70
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06167694
What this trial is testing

Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Who this might be right for
Unresectable or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT05275777
What this trial is testing

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Who this might be right for
HER2-negative Breast CancerAdvanced Solid Tumor
National University Hospital, Singapore 66
Not applicableActive Not RecruitingNCT04086875
What this trial is testing

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+18 more
Thomas Jefferson University 332
Load More Results